ExecuPharm, Subsidiary of US Biopharmaceutical Giant Parexel, Hit by Ransomware Attack

ExecuPharm, a subsidiary of the U.S. Biopharmaceutical giant Parexel, has been hit by a ransomware attack according to a recent announcement made by the company.
In a letter sent to the Office of The Vermont Attorney General, the company explains that on March 13, 2020, “a data security incident that compromised select corporate and personal information” happened after “unknown individual encrypted ExecuPharm servers and sought a ransom in exchange for decryption.”

Read the entire article here.

Posted in In the News.